Pasar al contenido principal

Yoelsis Garcia Mayea

Yoelsis García Mayea, Ph.D., is graduated in Biology by the University of Havana (Cuba) in 2010. He afterwards worked 2 years as a researcher in the area of bee genetics at the Institute of Beekeeping Research in Havana, where he collaborated closely with the Center of Molecular Immunology and the Center for Fisheries Research in Havana, publishing his first article related to the potential use of bee products against atherosclerosis. In 2015 Yoelsis was awarded a predoctoral fellowship from the Vall d'Hebron Hospital Research Institute (VHIR) (Barcelona), where he carried out the necessary research to successfully defend his PhD Thesis in Genetics (University of Barcelona) in 2020. During his predoctoral period he published 10 scientific articles in medium-high impact indexed biomedical journals and has participated in 4 national/international competitive projects. His research has been mainly focused on biomedical oncology research, more specifically on the study of cellular and molecular mechanisms responsible for the acquisition of resistance to chemotherapeutic treatments. As a postdoctoral researcher Yoelsis has continued his research career at the Vall d'Hebron Research Institute, and more recently he has been awarded with a "Margarita Salas" grant from the University of Barcelona, which will allow him to spend 2 years as a postdoctoral researcher at VHIR and at the Autonomous University of Barcelona. He currently has a total of 18 published scientific articles, collaborates as a reviewer in several journals (Autophagy, Cancers, Journal of Translational Medicine, Molecules, Medicina-Lithuania, Frontiers in Bioscience-Landmark, Translational Cancer Research), has directed 2 master's theses, and is co-director of a PhD Thesis. PREVIOUS EXPERIENCE IN LABORATORY WORK: Handling of experimental animals (mice). Molecular biology and molecular genetics: Western Blot; ELISA; qRT-PCR; Cloning; siRNA transfections/shRNA infections. Cell culture: Isolation and characterization of Cancer Stem Cells and establishment of primary cell cultures. Flow cytometry: cell cycle analysis; surface and intracellular markers. Confocal microscopy: analysis of intracellular markers and image processing. Electron microscopy: sample preparation, manipulation, and image acquisition. Biostatistical analysis. Design and writing of research projects.

Instituciones de las que forman parte

Investigador postdoctoral
Cáncer de cabeza y cuello: Investigación biomédica en células madre tumorales
Vall Hebron Institut de Recerca

Yoelsis Garcia Mayea

Instituciones de las que forman parte

Investigador postdoctoral
Cáncer de cabeza y cuello: Investigación biomédica en células madre tumorales
Vall Hebron Institut de Recerca

Yoelsis García Mayea, Ph.D., is graduated in Biology by the University of Havana (Cuba) in 2010. He afterwards worked 2 years as a researcher in the area of bee genetics at the Institute of Beekeeping Research in Havana, where he collaborated closely with the Center of Molecular Immunology and the Center for Fisheries Research in Havana, publishing his first article related to the potential use of bee products against atherosclerosis. In 2015 Yoelsis was awarded a predoctoral fellowship from the Vall d'Hebron Hospital Research Institute (VHIR) (Barcelona), where he carried out the necessary research to successfully defend his PhD Thesis in Genetics (University of Barcelona) in 2020. During his predoctoral period he published 10 scientific articles in medium-high impact indexed biomedical journals and has participated in 4 national/international competitive projects. His research has been mainly focused on biomedical oncology research, more specifically on the study of cellular and molecular mechanisms responsible for the acquisition of resistance to chemotherapeutic treatments. As a postdoctoral researcher Yoelsis has continued his research career at the Vall d'Hebron Research Institute, and more recently he has been awarded with a "Margarita Salas" grant from the University of Barcelona, which will allow him to spend 2 years as a postdoctoral researcher at VHIR and at the Autonomous University of Barcelona. He currently has a total of 18 published scientific articles, collaborates as a reviewer in several journals (Autophagy, Cancers, Journal of Translational Medicine, Molecules, Medicina-Lithuania, Frontiers in Bioscience-Landmark, Translational Cancer Research), has directed 2 master's theses, and is co-director of a PhD Thesis. PREVIOUS EXPERIENCE IN LABORATORY WORK: Handling of experimental animals (mice). Molecular biology and molecular genetics: Western Blot; ELISA; qRT-PCR; Cloning; siRNA transfections/shRNA infections. Cell culture: Isolation and characterization of Cancer Stem Cells and establishment of primary cell cultures. Flow cytometry: cell cycle analysis; surface and intracellular markers. Confocal microscopy: analysis of intracellular markers and image processing. Electron microscopy: sample preparation, manipulation, and image acquisition. Biostatistical analysis. Design and writing of research projects.

ORCID: 0000-0002-9395-7471

Proyectos

Degradadores moleculares de SFN para sensibilizar células tumorales de cabeza y cuello (HNSCC) resistentes a terapias convencionales (ANTCANRES)

IP: Matilde Lleonart Pajarin
Colaboradores: Yoelsis Garcia Mayea
Entidad financiadora: Fundació Institut Bioenginyeria de Catalunya
Financiación: 0.01
Referencia: K9086
Duración: 24/07/2023 - 24/07/2024

Establecimiento de una estrategia combinada en carcinoma escamoso de cabeza y cuello (HNSCC): una herramienta eficaz para superar los tumores quimiorresistentes.

IP: Matilde Lleonart Pajarin
Colaboradores: Katerin Ingrid Rojas Laimito, Yoelsis Garcia Mayea, Juan Lorente Guerrero, Sergio Benavente Norza, Josep Castellví Vives, Marina Bataller Fernández, Pablo Sanchez Sancho, Juan Fernando Fuentes Cabrera, Juan Fernando Fuentes Cabrera
Entidad financiadora: Instituto de Salud Carlos III
Financiación: 240000
Referencia: PI24/00630
Duración: 01/01/2025 - 31/12/2027

New compounds targeting head and neck cancer as Trojan horses against chemoresistant cells

IP: Matilde Lleonart Pajarin
Colaboradores: Yoelsis Garcia Mayea, Marina Bataller Fernández, Gabriela Isabel Fuentes Llopis
Entidad financiadora: Agència Gestió Ajuts Universitaris i de Recerca
Financiación: 20000
Referencia: 2023 LLAV 00102
Duración: 01/02/2024 - 31/07/2024

Therapeutical approaches against chemoresistant cancers

IP: Matilde Lleonart Pajarin
Colaboradores: Yoelsis Garcia Mayea, Fco. Xavier De la Cruz Montserrat, Juan Lorente Guerrero, Sergio Benavente Norza, Therapeutical approaches against chemoresistant cancers, Marina Bataller Fernández, Therapeutical approaches against chemoresistant cancers, Therapeutical approaches against chemoresistant cancers
Entidad financiadora: Agència Gestió Ajuts Universitaris i de Recerca
Financiación: 0.01
Referencia: 2021 SGR 01205
Duración: 01/01/2022 - 30/06/2025

Noticias relacionadas

Los expertos han abordado los principales retos actuales y futuros para mejorar las opciones terapéuticas de los pacientes con este tipo de tumor.

En el Día Mundial de la Investigación en Cáncer, el VHIR destaca los últimos avances para conocer los mecanismos biológicos del cáncer, mejorar los tratamientos existentes y la apuesta por la nanomedicina y las terapias avanzadas.

Un año después de una innovadora cirugía para extirparle un tumor parafaríngeo a través de la boca, Susana Zapico se reencuentra con el Dr. David Virós coincidiendo con el Día Mundial del Cáncer de Cabeza y Cuello. La nueva técnica, que combina tecnología 3D y cirugía robótica, ya se ha aplicado en quince pacientes más. Ahora, el equipo da un paso adelante hacia la cirugía con gemelos digitales.

Profesionales relacionados

Mercedes Martinez Mansilla

Mercedes Martinez Mansilla

Técnico de investigación
Patologia Molecular Translacional
Leer más
Maria Sellés Altés

Maria Sellés Altés

Técnico de investigación
Enfermedades Neurodegenerativas
Leer más
Itziar Busquets Saez

Itziar Busquets Saez

Técnico de investigación
Imagen y Terapia Molecular
Leer más
Adaia Albasanz Puig

Adaia Albasanz Puig

Investigador postdoctoral
Enfermedades Infecciosas
Leer más

Suscríbete a nuestros boletines y forma parte de la vida del Campus

Vall d'Hebron Barcelona Hospital Campus es un parque de referencia mundial donde la asistencia, la investigación, la docencia y la innovación se dan la mano.